Please log in to view this page
Username
Password
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
